|
|
Other links at Articles > Diabetes and Endocrinology |
| 2. |
Fenofibrate Not Cardioprotective in Diabetics
|
|
|
Long-term treatment with fenofibrate does not seem to reduce atherosclerosis, inflammation or endothelial dysfunction in patients with type 2 diabetes, according to a report in the December 16/23 issue of the Journal of the American College of Cardiology. Reuters Health Information
|
| 4. |
Longer Lactation Reduces the Risk of Metabolic Syndrome
|
|
|
Longer periods of lactation appear to lower the risk of metabolic syndrome (MetS) years after delivery and weaning, and particularly after gestational diabetes mellitus (GDM), a study published online December 3rd in Diabetes shows. Reuters Health Information
|
|
|